Ann: GTG COVID-19 Risk Test launched in USA, page-23

Really guys?!? IBX a trusted player in the US market. How much do you think it costs to sell a test across multiple media avenues eg internet, social media, tv, radio, magazines, billboards? Then there’s the cost of ground troop reps to clinician marketing. Marketing is not cheap. The royalty is 5.7% to sit back and trust IBX to do ALL the work. Massive potential here.

We have made it to market (most others don’t) and are one significant mutation away from this being the most wanted test in the world. Do your research on viral mutations throughout history. Even better, listen to the expert virologists around the world on the probability of further mutation.

I’d be very surprised if there’s not strong upward movement with this stock over the next month or so, once the pro’s stop playing with this current announcement.

All my opinion, of course. DYOR.